Savient Pharmaceuticals, Inc. (NASDAQ:SVNT)

CAPS Rating: 3 out of 5

A biopharmaceutical company engaged in developing and distributing pharmaceutical products that target unmet medical needs in both niche and broader markets.

Recs

0
Player Avatar sdbeck23 (64.50) Submitted: 2/3/2011 8:21:03 PM : Outperform Start Price: $9.83 SVNT Score: -92.23

why not

Featured Broker Partners


Advertisement